The Covid-19 pandemic has kept the focus on the pharmaceutical sector. In an iteration of such focus, CCI has upped its advocacy efforts, with an engagement with the industry and recommendations on antitrust concerns. To be sure, such studies also act as a precursor to increased scrutiny with the possibility of enforcement actions (like it did in e-commerce and in social media for data concerns).

 For more, click here